Biotech and Genetics Industry Trends, Statistics and Analysis 2011 (Summary) - Plunkett Research

Biotech and Genetics Industry Trends, Statistics and Analysis 2011 (Summary)

67 pages — Published Sep 20, 2011
Price $149.99  |  Buy this Report Now

About This Report

  
Abstract:

PLUNKETT'S BIOTECH & GENETICS INDUSTRY TRENDS & STATISTICS 2011

Key Features:

-Industry trends analysis, market data and competitive intelligence
-Market forecasts and Industry Statistics
-Buyer may register for access to search and export data at Plunkett Research Online

Pages: 67
Statistical Tables Provided: 21
Geographic Focus: Global

A condensed market research report excerpted from Plunkett?s Biotech & Genetics Industry Almanac 2011, including forecasts and market estimates, technologies analysis and vital statistical tables. You will gain significant insights that can help you shape your own strategy for business development, product development and investments.

-How is the industry evolving?
-How is the industry being shaped by new technologies?
-How is demand growing in emerging markets and mature economies?
-What is the size of the market now and in the future?

Contents, Statistics, Forecasts and Analysis Include:

Major Trends Affecting the Biotech & Genetics Industry
1) Ethanol Production Soared, But a Market Glut May Slow Expansion
2) Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms
3) From India to Singapore to Australia, Nations Compete Fiercely in Biotech Development
4) Medical Trials Conducted Abroad Spark Concerns
5) Gene Therapies and Patients? Genetic Profiles Promise a Personalized Approach to Medicine
6) Breakthrough Drugs for Cancer Treatment-Many More Will Follow
7) Few New Blockbusters: Major Drug Patents Expire While Generic Sales Growth Continues
8) Biogenerics (Follow-on Biologics) are in Limbo in the U.S.
9) Breakthrough Drug Delivery Systems Evolve
10) Stem Cells-Multiple Sources Stem from New Technologies
11) Stem Cells-Therapeutic Cloning Techniques Advance
12) Stem Cells-A New Era of Regenerative Medicine Takes Shape
13) Nanotechnology Converges with Biotech
14) Agricultural Biotechnology Scores Breakthroughs but Causes Controversy
15) Technology Discussion-Genomics
16) Technology Discussion-Proteomics
17) Technology Discussion-Microarrays
18) Technology Discussion-DNA Chips
19) Technology Discussion-SNPs
20) Technology Discussion-Combinatorial Chemistry
21) Technology Discussion-Synthetic Biology
22) Technology Discussion-Recombinant DNA

Biotech & Genetics Industry Statistics
1) U.S. FDA New Drug and Biologic Approvals, 2009
2) U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1993-2009
3) National Health Expenditure Amounts by Type of Expenditure, U.S.: Selected Calendar Years, 2004-2019
4) U.S. Exports & Imports of Pharmaceutical Products: 2005-1st Quarter 2010
5) U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: Selected Calendar Years, 2004-2019
6) U.S. Prescription Drug Expenditures: 1965-2019
7) Global Area of Biotech Crops by Country: 2009
8) R&D as a Percentage of U.S. Biopharmaceutical Sales, PhRMA Member Companies: 1970-2009
9) Biologics & Biotechnology R&D, PhRMA Member Companies: 2008
10) Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1975-2009
11) Domestic U.S. Biopharmaceutical R&D Breakdown, PhRMA Member Companies: 2008
12) Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1970-2009

  
Source:
Document ID
978-1-60879-803-2
Country
Country
Country
Country
Country
Country
Country
Country
Country
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Cover16
CONTENTS72
Chapter 1934
  The State of the Biotechnology Industry Today95
  A Short History of Biotechnology141
  Ethanol Production Soared, But a Market Glut May Slow Expansion153
  Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms181
  From India to Singapore to Australia, Nations Compete Fiercely in Biotech Development192
  Medical Trials Conducted Abroad Spark Concerns211
  Gene Therapies and Patients Genetic Profiles Promise a Personalized Approach to Medicine212
  Breakthrough Drugs for Cancer Treatment Many More Will Follow231
  Few New Blockbusters: Major Drug Patents Expire While Generic Sales Growth Continues242
  Biotech and Orphan Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age261
  Biogenerics (Follow-on Biologics) are in Limbo in the U.S.271
  Breakthrough Drug Delivery Systems Evolve281
  Stem Cells Multiple Sources Stem from New Technologies292
  U.S. Government Stance on Funding for New Stem Cell Research Unclear311
  Stem Cells Therapeutic Cloning Techniques Advance321
  Stem Cells A New Era of Regenerative Medicine Takes Shape331
  Nanotechnology Converges with Biotech341
  Agricultural Biotechnology Scores Breakthroughs but Causes Controversy/Selective Breeding Offers a Compromise353
  Focus on Vaccines381
  Ethical Issues Abound391
  Technology Discussion Genomics391
  Technology Discussion Proteomics401
  Technology Discussion Microarrays401
  Technology Discussion DNA Chips401
  Technology Discussion SNPs ( Snips )411
  Technology Discussion Combinatorial Chemistry411
  Technology Discussion Recombinant DNA421
  Technology Discussion Polymerase Chain Reaction (PCR)421
Chapter 24325
  Biotech Industry Overview441
  The U.S. Drug Discovery &Approval Process451
  U.S. FDA New Drug and Biologic Approvals, 2009461
  U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1993-2009471
  Employment in Life &Physical Science Occupations by Business Type, U.S.: May 2009481
  Federal R&D &R&D Plant Funding for General Science &Basic Research, U.S.: Fiscal Years 2008-2010491
  National Health Expenditure Amounts by Type of Expenditure, U.S.: Selected Calendar Years, 2004-2019501
  U.S. Exports &Imports of Pharmaceutical Products: 2005-1st Quarter 2010511
  U.S. Prescription Drug Expenditures, Aggregate &PerCapita Amounts, Percent Distribution: Selected Calendar Years, 2004-2019521
  U.S. Prescription Drug Expenditures: 1965-2019532
  Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2009551
  Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Year 2009-2011561
  Global Area of Biotech Crops by Country: 2009571
  R&D as a Percentage of U.S. Biopharmaceutical Sales, PhRMA Member Companies: 1970-2009581
  Biologics &Biotechnology R&D, PhRMA Member Companies: 2008591
  Domestic &Foreign Pharmaceutical Sales, PhRMA Member Companies: 1975-2009601
  Sales By Geographic Area, PhRMA Member Companies: 2008611
  Domestic U.S. Biopharmaceutical R&D Breakdown, PhRMA Member Companies: 2008621
  R&D by Global Geographic Area, PhRMA Member Companies: 2008631
  Domestic Biopharmaceutical R&D Scientific, Professional &Technical Personnel by Function, PhRMA Member Companies: 2008641
  Domestic U.S. Biopharmaceutical R&D &R&D Abroad, PhRMA Member Companies: 1970-2009653

Table Of Contents

Plunkett Research—Plunkett Research, Ltd., established in 1985, is a leading provider of business and industry information to the corporate, library, academic and government markets. We specialize in market research that analyzes industry trends, provides competitive intelligence and determines the scope and qualities of market leaders.

About the Author


Cite this Report

  
MLA:
Plunkett Research. "Biotech and Genetics Industry Trends, Statistics and Analysis 2011 (Summary)" Sep 20, 2011. Alacra Store. Jul 28, 2014. <http://www.alacrastore.com/storecontent/Plunkett-Research/Biotech-and-Genetics-Industry-Trends-Statistics-and-Analysis-2011-Summary-2082-778>
  
APA:
Plunkett Research. (2011). Biotech and Genetics Industry Trends, Statistics and Analysis 2011 (Summary) Sep 20, 2011. New York, NY: Alacra Store. Retrieved Jul 28, 2014 from <http://www.alacrastore.com/storecontent/Plunkett-Research/Biotech-and-Genetics-Industry-Trends-Statistics-and-Analysis-2011-Summary-2082-778>
  
$149.99
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.